ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Mirum Pharmaceuticals Inc

Mirum Pharmaceuticals Inc (MIRM)

41.32
-0.68
(-1.62%)
Closed January 10 3:00PM
41.32
-0.01
(-0.02%)
After Hours: 5:31PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
41.32
Bid
39.41
Ask
43.00
Volume
401,802
40.55 Day's Range 41.61
23.14 52 Week Range 48.89
Market Cap
Previous Close
42.00
Open
41.44
Last Trade Time
Financial Volume
US$ 16,553,715
VWAP
41.1987
Average Volume (3m)
374,900
Shares Outstanding
48,004,582
Dividend Yield
-
PE Ratio
-12.14
Earnings Per Share (EPS)
-3.4
Revenue
186.37M
Net Profit
-163.42M

About Mirum Pharmaceuticals Inc

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapies for debilitating liver diseases. It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC... Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapies for debilitating liver diseases. It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Dover, Delaware, USA
Founded
-
Mirum Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker MIRM. The last closing price for Mirum Pharmaceuticals was US$42. Over the last year, Mirum Pharmaceuticals shares have traded in a share price range of US$ 23.14 to US$ 48.89.

Mirum Pharmaceuticals currently has 48,004,582 shares outstanding. The market capitalization of Mirum Pharmaceuticals is US$2.02 billion. Mirum Pharmaceuticals has a price to earnings ratio (PE ratio) of -12.14.

MIRM Latest News

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that on January 10, 2025, the Compensation Committee of Mirum’s Board of Directors granted inducement awards consisting of non-qualified...

Mirum Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a biopharmaceutical company focused on the identification, acquisition, development and commercialization of novel therapies for debilitating rare and...

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that on December 10, 2024, the Compensation Committee of Mirum’s Board of Directors granted inducement awards consisting of...

Mirum Pharmaceuticals to Showcase Data from its LIVMARLI and Volixibat Clinical Programs at AASLD’s The Liver Meeting

- Late-breaker presentation to feature data from VANTAGE study evaluating volixibat in primary biliary cholangitis Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) today announced that it will present...

Mirum Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update

Third quarter global net product sales of $90.3 million; 2024 guidance increased to $330 - 335 million Volixibat granted breakthrough therapy designation for treatment of cholestatic pruritus in...

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that on November 8, 2024, the Compensation Committee of Mirum’s Board of Directors granted inducement awards consisting of non-qualified...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1.28-3.0046948356842.643.5241.3245263142.57764946CS
4-1-2.362948960342.3243.5240.0338642941.88759883CS
121.844.6605876393139.4848.8938.1537490042.44416924CS
264.6212.588555858336.748.8935.6343911341.16796626CS
5213.7950.090810025427.5348.8923.1452731233.56248054CS
15625.97169.18566775215.3548.8914.6344755728.68880456CS
26021.37107.11779448619.9548.899.1431496227.03259546CS

MIRM - Frequently Asked Questions (FAQ)

What is the current Mirum Pharmaceuticals share price?
The current share price of Mirum Pharmaceuticals is US$ 41.32
How many Mirum Pharmaceuticals shares are in issue?
Mirum Pharmaceuticals has 48,004,582 shares in issue
What is the market cap of Mirum Pharmaceuticals?
The market capitalisation of Mirum Pharmaceuticals is USD 2.02B
What is the 1 year trading range for Mirum Pharmaceuticals share price?
Mirum Pharmaceuticals has traded in the range of US$ 23.14 to US$ 48.89 during the past year
What is the PE ratio of Mirum Pharmaceuticals?
The price to earnings ratio of Mirum Pharmaceuticals is -12.14
What is the cash to sales ratio of Mirum Pharmaceuticals?
The cash to sales ratio of Mirum Pharmaceuticals is 10.65
What is the reporting currency for Mirum Pharmaceuticals?
Mirum Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Mirum Pharmaceuticals?
The latest annual turnover of Mirum Pharmaceuticals is USD 186.37M
What is the latest annual profit for Mirum Pharmaceuticals?
The latest annual profit of Mirum Pharmaceuticals is USD -163.42M
What is the registered address of Mirum Pharmaceuticals?
The registered address for Mirum Pharmaceuticals is 838 WALKER ROAD, SUITE 21-2, DOVER, DELAWARE, 19904
Which industry sector does Mirum Pharmaceuticals operate in?
Mirum Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
VRMEVerifyMe Inc
US$ 2.57
(52.98%)
57.7M
WKEYWISeKey International Holdings AG
US$ 10.041
(52.83%)
6.69M
DATSDatChat Inc
US$ 4.8105
(49.86%)
158.55M
CDTConduit Pharmaceuticals Inc
US$ 0.1214
(48.05%)
1.16B
INTZIntrusion Inc
US$ 2.8888
(44.44%)
40.45M
IGMSIGM Biosciences Inc
US$ 2.095
(-66.21%)
5.81M
CDTGCDT Environmental Technology Investment Holdings Ltd
US$ 1.87
(-51.30%)
2.28M
MODVModivCare Inc
US$ 6.51
(-47.88%)
2.73M
AIFUAIX Inc
US$ 0.420501
(-47.76%)
7.85M
MRSNMersana Therapeutics Inc
US$ 0.691
(-46.85%)
58.44M
CDTConduit Pharmaceuticals Inc
US$ 0.1214
(48.05%)
1.17B
NVDANVIDIA Corporation
US$ 135.91
(-3.00%)
207.51M
RGTIRigetti Computing Inc
US$ 8.9299
(-11.06%)
178.77M
VMARVision Marine Technologies Inc
US$ 2.14
(40.79%)
175.57M
DATSDatChat Inc
US$ 4.8105
(49.86%)
158.63M